Virginia Kaklamani
Publications by Year
Research Areas
Advanced Breast Cancer Therapies, Cancer Treatment and Pharmacology, HER2/EGFR in Cancer Research, Breast Cancer Treatment Studies, Estrogen and related hormone effects
Most-Cited Works
- → Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer(2018)2,319 cited
- → Prospective Validation of a 21-Gene Expression Assay in Breast Cancer(2015)1,425 cited
- → Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies(2019)1,057 cited
- → Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease(2010)670 cited
- → Genetic/Familial High-Risk Assessment: Breast and Ovarian(2010)650 cited
- → Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial(2022)641 cited
- → Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer(2019)538 cited
- → Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial(2020)302 cited
- → Synchronicity of frequently sampled, 24-h concentrations of circulating leptin, luteinizing hormone, and estradiol in healthy women(1998)294 cited
- → Leptin Concentrations in Relation to Body Mass Index and the Tumor Necrosis Factor-α System in Humans1(1997)273 cited